Skip to main content
Erschienen in: Clinical and Translational Oncology 6/2023

02.01.2023 | RESEARCH ARTICLE

LncRNA HOTAIR enhances RCC2 to accelerate cervical cancer progression by sponging miR-331-3p

verfasst von: Gulimire Buranjiang, Ailikemu Abuduwanke, Xiaowen Li, Guzalinuer Abulizi

Erschienen in: Clinical and Translational Oncology | Ausgabe 6/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Long noncoding RNAs (lncRNAs) have been gradually regarded as influential indicators of various cancers. The present study aimed to identify the effects of lncRNA HOTAIR on cervical cancer progression.

Methods

RNA and protein expressions were quantified by RT-qPCR and western blot assays. Fluorescence in situ hybridization (FISH) assay was carried out to examine the intracellular location of HOTAIR. Cancer cell viability and mobility were detected by CCK-8, colony formation, transwell and wound healing assays. Binding relationships between miR-331-3p and HOTAIR/RCC2 were validated by luciferase reporter assay.

Results

RT-qPCR assays showed that HOTAIR levels were notably upregulated in cervical cancer tissues and cell lines. Furthermore, a fluorescence in situ hybridization (FISH) assay suggested that HOTAIR was mostly located in the cytoplasm of cancer cells, indicating a sponging function. CCK-8, colony formation, Transwell and wound-healing assays indicated that knockdown of HOTAIR in HeLa and SiHa cells significantly reduced cell growth, migration and invasion. Subsequently, miR-331-3p was proven to be the target molecule of HOTAIR. In addition, results from Pearson's correlation analysis indicated negative correlation between HOTAIR and miR-331-3p in cervical cancer tissues. HOTAIR negatively modulated miR-331-3p expression. Ultimately, the target gene of miR-331-3p was verified to be RCC2, and miR-331-3p negatively modulated RCC2 expression. In addition, analysis on clinical cervical cancer tissues confirmed the negative correlation between miR-331-3p and RCC2. HOTAIR and RCC2 showed oncogenic functions in HeLa and SiHa cells, while miR-331-3p exerted the reverse effect.

Conclusions

HOTAIR plays a carcinogenic role in cervical cancer by targeting the miR-331-3p/RCC2 axis. Moreover, clinical cervical cancer tissues confirmed the negative correlation between miR-331-3p with lncRNA HOTAIR and RCC2. These data suggested an underlying therapeutic target for cervical cancer.
Literatur
1.
Zurück zum Zitat Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.CrossRefPubMed Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.CrossRefPubMed
3.
Zurück zum Zitat Vaccarella S, Franceschi S, Zaridze D, Poljak M, Veerus P, Plummer M, et al. Preventable fractions of cervical cancer via effective screening in six Baltic, central, and eastern European countries 2017–40: a population-based study. Lancet Oncol. 2016;17:1445–52.CrossRefPubMedPubMedCentral Vaccarella S, Franceschi S, Zaridze D, Poljak M, Veerus P, Plummer M, et al. Preventable fractions of cervical cancer via effective screening in six Baltic, central, and eastern European countries 2017–40: a population-based study. Lancet Oncol. 2016;17:1445–52.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Fattahi S, Kosari-Monfared M, Golpour M, Emami Z, Ghasemiyan M, Nouri M, et al. LncRNAs as potential diagnostic and prognostic biomarkers in gastric cancer: A novel approach to personalized medicine. J Cell Physiol. 2020;235:3189–206.CrossRefPubMed Fattahi S, Kosari-Monfared M, Golpour M, Emami Z, Ghasemiyan M, Nouri M, et al. LncRNAs as potential diagnostic and prognostic biomarkers in gastric cancer: A novel approach to personalized medicine. J Cell Physiol. 2020;235:3189–206.CrossRefPubMed
5.
Zurück zum Zitat Javed Z, Ahmed Shah F, Rajabi S, Raza Q, Iqbal Z, Ullah M, et al. LncRNAs as Potential Therapeutic Targets in Thyroid Cancer. Asian Pac J Cancer Prev. 2020;21:281–7.CrossRefPubMedPubMedCentral Javed Z, Ahmed Shah F, Rajabi S, Raza Q, Iqbal Z, Ullah M, et al. LncRNAs as Potential Therapeutic Targets in Thyroid Cancer. Asian Pac J Cancer Prev. 2020;21:281–7.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Dastmalchi N, Safaralizadeh R, Nargesi MM. LncRNAs: Potential Novel Prognostic and Diagnostic Biomarkers in Colorectal Cancer. Curr Med Chem. 2020;27:5067–77.CrossRefPubMed Dastmalchi N, Safaralizadeh R, Nargesi MM. LncRNAs: Potential Novel Prognostic and Diagnostic Biomarkers in Colorectal Cancer. Curr Med Chem. 2020;27:5067–77.CrossRefPubMed
7.
Zurück zum Zitat Aalijahan H, Ghorbian S. Long noncoding RNAs and cervical cancer. Exp Mol Pathol. 2019;106:7–16.CrossRefPubMed Aalijahan H, Ghorbian S. Long noncoding RNAs and cervical cancer. Exp Mol Pathol. 2019;106:7–16.CrossRefPubMed
8.
Zurück zum Zitat Hua JT, Chen S, He HH. Landscape of Noncoding RNA in Prostate Cancer. Trends Genet. 2019;35:840–51.CrossRefPubMed Hua JT, Chen S, He HH. Landscape of Noncoding RNA in Prostate Cancer. Trends Genet. 2019;35:840–51.CrossRefPubMed
9.
Zurück zum Zitat Paraskevopoulou MD, Hatzigeorgiou AG. Analysing MiRNA-LncRNA Interactions. Methods Mol Biol. 2016;1402:271–86.CrossRefPubMed Paraskevopoulou MD, Hatzigeorgiou AG. Analysing MiRNA-LncRNA Interactions. Methods Mol Biol. 2016;1402:271–86.CrossRefPubMed
10.
Zurück zum Zitat Wang Z, Liu Y. Predicting Functional MicroRNA-mRNA Interactions. Methods Mol Biol. 2017;1580:117–26.CrossRefPubMed Wang Z, Liu Y. Predicting Functional MicroRNA-mRNA Interactions. Methods Mol Biol. 2017;1580:117–26.CrossRefPubMed
11.
Zurück zum Zitat Chen LL. Linking Long Noncoding RNA Localization and Function. Trends Biochem Sci. 2016;41:761–72.CrossRefPubMed Chen LL. Linking Long Noncoding RNA Localization and Function. Trends Biochem Sci. 2016;41:761–72.CrossRefPubMed
12.
Zurück zum Zitat Xu J, Zhang J. LncRNA TP73-AS1 is a novel regulator in cervical cancer via miR-329-3p/ARF1 axis. J Cell Biochem. 2020;121:344–52.CrossRefPubMed Xu J, Zhang J. LncRNA TP73-AS1 is a novel regulator in cervical cancer via miR-329-3p/ARF1 axis. J Cell Biochem. 2020;121:344–52.CrossRefPubMed
13.
Zurück zum Zitat Liang H, Zhang C, Guan H, Liu J, Cui Y. LncRNA DANCR promotes cervical cancer progression by upregulating ROCK1 by sponging miR-335-5p. J Cell Physiol. 2019;234:7266–78.CrossRefPubMed Liang H, Zhang C, Guan H, Liu J, Cui Y. LncRNA DANCR promotes cervical cancer progression by upregulating ROCK1 by sponging miR-335-5p. J Cell Physiol. 2019;234:7266–78.CrossRefPubMed
14.
Zurück zum Zitat Hu T, Zhang Q, Gao L. LncRNA CAR10 Upregulates PDPK1 to Promote Cervical Cancer Development by Sponging miR-125b-5p. Biomed Res Int. 2020;2020:4351671.CrossRefPubMedPubMedCentral Hu T, Zhang Q, Gao L. LncRNA CAR10 Upregulates PDPK1 to Promote Cervical Cancer Development by Sponging miR-125b-5p. Biomed Res Int. 2020;2020:4351671.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Liu M, Jia J, Wang X, Liu Y, Wang C, Fan R. Long noncoding RNA HOTAIR promotes cervical cancer progression through regulating BCL2 by targeting miR-143-3p. Cancer Biol Ther. 2018;19:391–9.CrossRefPubMedPubMedCentral Liu M, Jia J, Wang X, Liu Y, Wang C, Fan R. Long noncoding RNA HOTAIR promotes cervical cancer progression through regulating BCL2 by targeting miR-143-3p. Cancer Biol Ther. 2018;19:391–9.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Liu XH, Sun M, Nie FQ, Ge YB, Zhang EB, Yin DD, et al. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Mol Cancer. 2014;13:92.CrossRefPubMedPubMedCentral Liu XH, Sun M, Nie FQ, Ge YB, Zhang EB, Yin DD, et al. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Mol Cancer. 2014;13:92.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Wu J, Jin L, Zhang Y, Duan A, Liu J, Jiang Z, et al. LncRNA HOTAIR promotes endometrial fibrosis by activating TGF-β1/Smad pathway. Acta Biochim Biophys Sin (Shanghai). 2020;52:1337–47.CrossRefPubMed Wu J, Jin L, Zhang Y, Duan A, Liu J, Jiang Z, et al. LncRNA HOTAIR promotes endometrial fibrosis by activating TGF-β1/Smad pathway. Acta Biochim Biophys Sin (Shanghai). 2020;52:1337–47.CrossRefPubMed
18.
Zurück zum Zitat Sun Y, Hu ZQ. LncRNA HOTAIR aggravates myocardial ischaemia-reperfusion injury by sponging microRNA-126 to upregulate SRSF1. Eur Rev Med Pharmacol Sci. 2020;24:9046–54.PubMed Sun Y, Hu ZQ. LncRNA HOTAIR aggravates myocardial ischaemia-reperfusion injury by sponging microRNA-126 to upregulate SRSF1. Eur Rev Med Pharmacol Sci. 2020;24:9046–54.PubMed
19.
Zurück zum Zitat Mao T, He C, Wu H, Yang B, Li X. Silencing lncRNA HOTAIR declines synovial inflammation and synoviocyte proliferation and promotes synoviocyte apoptosis in osteoarthritis rats by inhibiting Wnt/β-catenin signaling pathway. Cell Cycle. 2019;18:3189–205.CrossRefPubMedPubMedCentral Mao T, He C, Wu H, Yang B, Li X. Silencing lncRNA HOTAIR declines synovial inflammation and synoviocyte proliferation and promotes synoviocyte apoptosis in osteoarthritis rats by inhibiting Wnt/β-catenin signaling pathway. Cell Cycle. 2019;18:3189–205.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Zhou W, He X, Chen Z, Fan D, Wang Y, Feng H, et al. LncRNA HOTAIR-mediated Wnt/β-catenin network modelling to predict and validate therapeutic targets for cartilage damage. BMC Bioinformatics. 2019;20:412.CrossRefPubMedPubMedCentral Zhou W, He X, Chen Z, Fan D, Wang Y, Feng H, et al. LncRNA HOTAIR-mediated Wnt/β-catenin network modelling to predict and validate therapeutic targets for cartilage damage. BMC Bioinformatics. 2019;20:412.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Lin Q, Hou S, Dai Y, Jiang N, Lin Y. LncRNA HOTAIR targets miR-126-5p to promote the progression of Parkinson’s disease through RAB3IP. Biol Chem. 2019;400:1217–28.CrossRefPubMed Lin Q, Hou S, Dai Y, Jiang N, Lin Y. LncRNA HOTAIR targets miR-126-5p to promote the progression of Parkinson’s disease through RAB3IP. Biol Chem. 2019;400:1217–28.CrossRefPubMed
22.
Zurück zum Zitat Gao L, Wang X, Guo S, Xiao L, Liang C, Wang Z, et al. LncRNA HOTAIR functions as a competing endogenous RNA to upregulate SIRT1 by sponging miR-34a in diabetic cardiomyopathy. J Cell Physiol. 2019;234:4944–58.CrossRefPubMed Gao L, Wang X, Guo S, Xiao L, Liang C, Wang Z, et al. LncRNA HOTAIR functions as a competing endogenous RNA to upregulate SIRT1 by sponging miR-34a in diabetic cardiomyopathy. J Cell Physiol. 2019;234:4944–58.CrossRefPubMed
23.
Zurück zum Zitat Zhao W, Geng D, Li S, Chen Z, Sun M. LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer. Cancer Med. 2018;7:842–55.CrossRefPubMedPubMedCentral Zhao W, Geng D, Li S, Chen Z, Sun M. LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer. Cancer Med. 2018;7:842–55.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Peng CL, Zhao XJ, Wei CC, Wu JW. LncRNA HOTAIR promotes colon cancer development by downregulating miRNA-34a. Eur Rev Med Pharmacol Sci. 2019;23:5752–61.PubMed Peng CL, Zhao XJ, Wei CC, Wu JW. LncRNA HOTAIR promotes colon cancer development by downregulating miRNA-34a. Eur Rev Med Pharmacol Sci. 2019;23:5752–61.PubMed
25.
Zurück zum Zitat Yan ZC, He L, Qiu JH, Deng WT, Lu JR, Yuan Z, et al. LncRNA HOTAIR participates in the development and progression of adrenocortical carcinoma by regulating cell cycle. Eur Rev Med Pharmacol Sci. 2018;22:6640–9.PubMed Yan ZC, He L, Qiu JH, Deng WT, Lu JR, Yuan Z, et al. LncRNA HOTAIR participates in the development and progression of adrenocortical carcinoma by regulating cell cycle. Eur Rev Med Pharmacol Sci. 2018;22:6640–9.PubMed
26.
Zurück zum Zitat Zhang H, Wang R, Wang M. miR-331-3p suppresses cell invasion and migration in colorectal carcinoma by directly targeting NRP2. Oncol Lett. 2019;18:6501–8.PubMedPubMedCentral Zhang H, Wang R, Wang M. miR-331-3p suppresses cell invasion and migration in colorectal carcinoma by directly targeting NRP2. Oncol Lett. 2019;18:6501–8.PubMedPubMedCentral
27.
Zurück zum Zitat Tian QQ, Xia J, Zhang X, Gao BQ, Wang W. miR-331-3p Inhibits Tumor Cell Proliferation, Metastasis, Invasion by Targeting MLLT10 in Non-Small Cell Lung Cancer. Cancer Manag Res. 2020;12:5749–58.CrossRefPubMedPubMedCentral Tian QQ, Xia J, Zhang X, Gao BQ, Wang W. miR-331-3p Inhibits Tumor Cell Proliferation, Metastasis, Invasion by Targeting MLLT10 in Non-Small Cell Lung Cancer. Cancer Manag Res. 2020;12:5749–58.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Zhao M, Zhang M, Tao Z, Cao J, Wang L, Hu X. miR-331-3p Suppresses Cell Proliferation in TNBC Cells by Downregulating NRP2. Technol Cancer Res Treat. 2020;19:1533033820905824.CrossRefPubMedPubMedCentral Zhao M, Zhang M, Tao Z, Cao J, Wang L, Hu X. miR-331-3p Suppresses Cell Proliferation in TNBC Cells by Downregulating NRP2. Technol Cancer Res Treat. 2020;19:1533033820905824.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Yu H, Zhang S, Ibrahim AN, Wang J, Deng Z, Wang M. RCC2 promotes proliferation and radio-resistance in glioblastoma by activating transcription of DNMT1. Biochem Biophys Res Commun. 2019;516:999–1006.CrossRefPubMed Yu H, Zhang S, Ibrahim AN, Wang J, Deng Z, Wang M. RCC2 promotes proliferation and radio-resistance in glioblastoma by activating transcription of DNMT1. Biochem Biophys Res Commun. 2019;516:999–1006.CrossRefPubMed
30.
Zurück zum Zitat Calderon-Aparicio A, Yamamoto H, De Vitto H, Zhang T, Wang Q, Bode AM, et al. RCC2 Promotes Esophageal Cancer Growth by Regulating Activity and Expression of the Sox2 Transcription Factor. Mol Cancer Res. 2020;18:1660–74.CrossRefPubMed Calderon-Aparicio A, Yamamoto H, De Vitto H, Zhang T, Wang Q, Bode AM, et al. RCC2 Promotes Esophageal Cancer Growth by Regulating Activity and Expression of the Sox2 Transcription Factor. Mol Cancer Res. 2020;18:1660–74.CrossRefPubMed
31.
Zurück zum Zitat Chen Z, Wu W, Huang Y, Xie L, Li Y, Chen H, et al. RCC2 promotes breast cancer progression through regulation of Wnt signaling and inducing EMT. J Cancer. 2019;10:6837–47.CrossRefPubMedPubMedCentral Chen Z, Wu W, Huang Y, Xie L, Li Y, Chen H, et al. RCC2 promotes breast cancer progression through regulation of Wnt signaling and inducing EMT. J Cancer. 2019;10:6837–47.CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Chen Q, Jiang P, Jia B, Liu Y, Zhang Z. RCC2 contributes to tumor invasion and chemoresistance to cisplatin in hepatocellular carcinoma. Hum Cell. 2020;33:709–20.CrossRefPubMed Chen Q, Jiang P, Jia B, Liu Y, Zhang Z. RCC2 contributes to tumor invasion and chemoresistance to cisplatin in hepatocellular carcinoma. Hum Cell. 2020;33:709–20.CrossRefPubMed
33.
Zurück zum Zitat Zhang M, Song Y, Zhai F. ARFHPV E7 oncogene, lncRNA HOTAIR, miR-331-3p and its target, NRP2, form a negative feedback loop to regulate the apoptosis in the tumorigenesis in HPV positive cervical cancer. J Cell Biochem. 2018;119:4397–407.CrossRefPubMed Zhang M, Song Y, Zhai F. ARFHPV E7 oncogene, lncRNA HOTAIR, miR-331-3p and its target, NRP2, form a negative feedback loop to regulate the apoptosis in the tumorigenesis in HPV positive cervical cancer. J Cell Biochem. 2018;119:4397–407.CrossRefPubMed
Metadaten
Titel
LncRNA HOTAIR enhances RCC2 to accelerate cervical cancer progression by sponging miR-331-3p
verfasst von
Gulimire Buranjiang
Ailikemu Abuduwanke
Xiaowen Li
Guzalinuer Abulizi
Publikationsdatum
02.01.2023
Verlag
Springer International Publishing
Erschienen in
Clinical and Translational Oncology / Ausgabe 6/2023
Print ISSN: 1699-048X
Elektronische ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-022-03059-4

Weitere Artikel der Ausgabe 6/2023

Clinical and Translational Oncology 6/2023 Zur Ausgabe

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Bessere Prognose mit links- statt rechtsseitigem Kolon-Ca.

06.05.2024 Kolonkarzinom Nachrichten

Menschen mit linksseitigem Kolonkarzinom leben im Mittel zweieinhalb Jahre länger als solche mit rechtsseitigem Tumor. Auch aktuell ist das Sterberisiko bei linksseitigen Tumoren US-Daten zufolge etwa um 11% geringer als bei rechtsseitigen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.